Cancer treatments have better outcomes if the disease is caught early, but unfortunately symptoms often don’t present until later. A new Oxford study demonstrates an experimental blood test that shows ...
OXFORD, England, February 05, 2025--(BUSINESS WIRE)--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics ...
OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch ® 3D genomics platform, today ...
A new blood test developed by the University of Oxford is showing "real promise" in detecting multiple types of cancer in ...
OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for immune health based on its EpiSwitch 3D genomics ...
A new at-home test for type-1 diabetes is being investigated by a major UK study led by researchers in Oxford. The study, led by the National Institute for Health and Care Research Oxford Biomedical ...
Bupa UK insurance customers with a raised PSA level and no additional high risk factors or symptoms will now be covered for PSE, a smart blood test which accurately predicts the presence or absence of ...
Scientists at the University of Oxford have developed a new coronavirus test that produces results around three times faster than the current fastest testing methods, and that requires only relatively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback